The first of the Copan White papers explores monkeypox diagnosis and international guidelines, suggesting Copan products that can be used to prevent the spread of the disease.
Since May 2022, few cases of monkeypox infection have been identified in 12 states members of the World Health Organization. The fact that these cases do not seem to have travel links to countries where monkeypox is endemic has put the WHO and other prevention organizations worldwide on alert, with the release of interim guidelines and information about the monkeypox virus and how to diagnose it. Here we briefly report a summary of these guidelines and how Copan products can be used to prevent the spread of the disease effectively.
Read the full document at the link below: